| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/10/2009 | US7501130 Methods for treating myofascial pain |
| 03/10/2009 | US7501129 Vectors comprising guinea pig CMV regulatory elements |
| 03/10/2009 | US7501128 DNA expression vector comprising a portion of a rhabdovirus G protein and further comprising on the same vector a portion of a second protein coding sequence from a pathogenic organism other than said rhabdovirus, with a pharmaceutically acceptable carrier; diseases in fish |
| 03/10/2009 | US7501127 Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara |
| 03/10/2009 | US7501126 Targeting of herpes simplex virus to specific receptors |
| 03/10/2009 | US7501125 Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent |
| 03/10/2009 | US7501124 Administering allogenic or xenogeneric cell; complexing with antigen |
| 03/10/2009 | US7501122 Treating ErbB2-expressing breast cancer in a human by administering huMAb4D5-8 antibody and humanized 2C4 antibody variant 574 |
| 03/10/2009 | US7501121 IL-13 binding agents |
| 03/10/2009 | US7501120 Humanized antibody binds to CD19 chemically coupled to a maytansinoid that is N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine or N2'-deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)-maytansine; sodium citrate, acetate, or succinate buffer; polysorbate, sodium chloride and water; antitumor agents |
| 03/10/2009 | US7501119 Methods and molecules for modulating an immune response |
| 03/10/2009 | US7501118 Human gene relating to respiratory diseases and obesity |
| 03/10/2009 | CA2329255C Method of producing thy a-strains of vibrio cholerae, such strains and their use |
| 03/10/2009 | CA2252896C Inactivation resistant factor viii |
| 03/10/2009 | CA2145278C Target binding polypeptide |
| 03/05/2009 | WO2009029883A2 Methods and compositions for modulating t cells |
| 03/05/2009 | WO2009029831A1 Methods and compositions related to immunizing against staphylococcal lung diseases and conditions |
| 03/05/2009 | WO2009029695A1 Method for producing viral vaccines |
| 03/05/2009 | WO2009029686A1 Immunogenic compositions and methods |
| 03/05/2009 | WO2009029669A1 Method of inhibiting complement activation with factor bb specific antibodies |
| 03/05/2009 | WO2009029569A1 Hiv env proteins with modifications in the v3 loop |
| 03/05/2009 | WO2009029272A2 Epitope vaccine for prevention and reversion of ad pathology |
| 03/05/2009 | WO2009029132A2 Antigen-binding proteins targeting s. aureus orf0657n |
| 03/05/2009 | WO2009028968A1 Cell marker of melanocyte cell lineage and uses thereof |
| 03/05/2009 | WO2009028663A1 Anti-claudin-3 antibody |
| 03/05/2009 | WO2009028639A1 Anti-epha2 antibody |
| 03/05/2009 | WO2009028605A1 Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
| 03/05/2009 | WO2009028580A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
| 03/05/2009 | WO2009028411A1 Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same |
| 03/05/2009 | WO2009028319A1 Peptide derived from ephb6 mutant capable of binding to hla-a24 or hla-a2 molecule |
| 03/05/2009 | WO2009028158A1 Dkk1 oncogene as therapeutic target for cancer and a diagnosing marker |
| 03/05/2009 | WO2009027768A2 Immunogenic compositions for gram positive bacteria |
| 03/05/2009 | WO2009027752A2 Process for producing hepcidin |
| 03/05/2009 | WO2009027688A1 Influenza antigen delivery vectors and constructs |
| 03/05/2009 | WO2009027470A1 LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS |
| 03/05/2009 | WO2009027412A1 A recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi |
| 03/05/2009 | WO2009027332A1 A modulator of nrg1 for treatment of respiratory disorders |
| 03/05/2009 | WO2009027105A2 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders |
| 03/05/2009 | WO2009026723A1 Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 03/05/2009 | WO2009026692A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/05/2009 | WO2009026681A1 Methods of inhibiting tumor growth using beta 5 integrin antagonists |
| 03/05/2009 | WO2009026638A1 Marine-animal derived therapeutic and diagnostic agents for hepatitis b |
| 03/05/2009 | WO2009026615A1 Group a streptococcus pharmaceutical compositions and methods thereof |
| 03/05/2009 | WO2009006479A3 Methods and compositions for producing an adenovirus vector for use with multiple vaccinations |
| 03/05/2009 | WO2009000824A3 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 03/05/2009 | WO2008157263A3 Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same |
| 03/05/2009 | WO2008155120A3 Methods and compositions for treating mucositis |
| 03/05/2009 | WO2008147434A9 TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN αVβ6 |
| 03/05/2009 | WO2008142509A3 Class a oligonucleotides with immunostimulatory potency |
| 03/05/2009 | WO2008133984A4 Combinations of gene deletions for live attenuated shigella vaccine strains |
| 03/05/2009 | WO2008115319A3 Conjugates of synthetic tlr agonists and uses therefor |
| 03/05/2009 | WO2008105886A3 HUMANIZED FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
| 03/05/2009 | WO2008063776A3 Antibodies to lymphotoxin-alpha |
| 03/05/2009 | WO2007111661A3 Human antibodies specific for gastrin materials and methods |
| 03/05/2009 | WO2005014618A3 Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| 03/05/2009 | US20090062194 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/05/2009 | US20090061521 Recombinant negative strand RNA virus expression systems and vaccines |
| 03/05/2009 | US20090061514 Use of cytokines and mitogens to inhibit graft versus host disease |
| 03/05/2009 | US20090061511 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 03/05/2009 | US20090061010 Cancer cell targeting using nanoparticles |
| 03/05/2009 | US20090060988 Nell-1 enhanced bone mineralization |
| 03/05/2009 | US20090060970 Compositions and methods of administering paclitaxel with other drugs using medical devices |
| 03/05/2009 | US20090060954 Recombinant BCG Vaccine |
| 03/05/2009 | US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 03/05/2009 | US20090060952 Production of the lipidated form of the peptidoglycan-associated liproproteins of gram-negative bacteria |
| 03/05/2009 | US20090060951 Dna vaccine for koi herpes virus (khv) disease |
| 03/05/2009 | US20090060950 Method for Producing Viral Vaccines |
| 03/05/2009 | US20090060949 Flu vaccines and methods of use thereof |
| 03/05/2009 | US20090060948 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
| 03/05/2009 | US20090060947 Immunological compositions |
| 03/05/2009 | US20090060946 Activation of antigen-specific T cells by virus/antigen-treated dendritic cells |
| 03/05/2009 | US20090060945 Integration of meningococcal conjugate vaccination |
| 03/05/2009 | US20090060938 Polyvalent Conjugate Vaccine for Cancer |
| 03/05/2009 | US20090060937 Immunostimulatory oligonucleotides and uses thereof |
| 03/05/2009 | US20090060936 Ii-Key/Her-2/neu hybrid cancer vaccine |
| 03/05/2009 | US20090060935 Amebiasis vaccine |
| 03/05/2009 | US20090060934 S. agalactiae antigens i & ii |
| 03/05/2009 | US20090060933 Proteases producing an altered immunogenic response and methods of making and using the same |
| 03/05/2009 | US20090060932 Immunizing an animal against Lyme disease by administering composition of at least two OspC polypeptides from Lyme Disease causing Borrelia comprising unlipidated and lipidated OspC polypeptides |
| 03/05/2009 | US20090060930 Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes |
| 03/05/2009 | US20090060929 Gene therapy and vaccination; non-viral transfection complex of a nucleic acid, optionally, a lipid,a polycationic nucleic acid-binding component, and a cell surface receptor binding peptide of given sequence |
| 03/05/2009 | US20090060928 Topical Toll Like Receptor Ligands as Vaccine Adjuvants |
| 03/05/2009 | US20090060927 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 03/05/2009 | US20090060926 Medicine for treatment of carcinoma |
| 03/05/2009 | US20090060925 Rage Fusion Proteins and Methods of Use |
| 03/05/2009 | US20090060924 having high affinity and strong neutralizing properties; increasing bone mass, bone mineral density and bone strength and for the treatment of various disorders, e.g. osteoporosis |
| 03/05/2009 | US20090060923 Method of treating or preventing an IL-1 related disease or condition |
| 03/05/2009 | US20090060922 Acetamide Stereoisomer |
| 03/05/2009 | US20090060921 Glycan-optimized anti-cd20 antibodies |
| 03/05/2009 | US20090060920 Desacyl ghrelin antibodies and therapeutic uses thereof |
| 03/05/2009 | US20090060919 BINDING MEMBERS FOR IgE MOLECULES |
| 03/05/2009 | US20090060918 Method of treating or preventing an IL-1 related disease or condition |
| 03/05/2009 | US20090060917 methyl [2-hydroxy-5-[1-hydroxy-2-[[(2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-phenyl] carbamate; water-stable, long acting beta 2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like |
| 03/05/2009 | US20090060916 Ligands that bind IL-4 and/or IL-13 |
| 03/05/2009 | US20090060915 Polypeptide, vaccine and use thereof |
| 03/05/2009 | US20090060914 Deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection |
| 03/05/2009 | US20090060913 Combination therapy with type i and type ii anti-cd20 antibodies |
| 03/05/2009 | US20090060912 Small molecule pi 3-kinase inhibitors and methods of their use |
| 03/05/2009 | US20090060911 Enhancement of antibody-mediated immune responses |
| 03/05/2009 | US20090060910 Covalent diabodies and uses thereof |